News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
Using data from the UK Biobank, a Harvard Medical School-led team of researchers has uncovered 15 new loci associated with coronary artery disease.
The two firms are offering a combined genetic disease risk and pharmacogenomic analysis that covers 49 conditions and about 220 medications.
A Canadian research team has reported beta-blockers alter the gene expression changes that take place in a mouse model of heart failure.
The international team says its findings may explain the evolutionary reasons for the maintenance of coronary artery disease in human populations.
Researchers found that certain somatic mutations in blood stem cells elevate coronary heart disease risk, likely by accelerating atherosclerosis.
